Data Supporting the Cardiovascular Safety of VIVUS' Qsymia® Published in The Journal of Clinical Endocrinology & Metabolism

Author's Avatar
Jan 14, 2019
Article's Main Image

-Study finds no increase in risk for major adverse cardiovascular events for individuals currently using phentermine in combination with topiramate; study adds to robust data supporting the safety and efficacy of Qsymia-